Ocular Therapeutix, Inc.OCULNASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank77
3Y CAGR-1.1%
5Y CAGR+24.3%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
-1.1%/yr
vs +135.6%/yr prior
5Y CAGR
+24.3%/yr
Recent deceleration
Acceleration
-136.7pp
Decelerating
Percentile
P77
Within normal range
vs 5Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$45.38M-21.9%
2024$58.10M+9.3%
2023$53.16M+13.2%
2022$46.95M+20.0%
2021$39.12M+155.3%
2020$15.32M+705.5%
2019$1.90M+24.7%
2018$1.52M+4.0%
2017$1.47M+1.5%
2016$1.44M-